Nathalie Moll shares her views on the pharma industry’s response to COVID-19 and Europe’s preparedness for future health crises. She also discusses the reach and ambition of the Pharma Strategy and addresses the issues around equitable access.
"The pandemic was an intense microcosm of some of our wider healthcare challenges and focused attention on areas that can be improved. There is a need to look for longer-term health outcomes, focus on early care prevention, digitalization, telemedicine and new payment models."
You are invited to EFPIA 2022 Conference.
Read more
World Environment Day
Join us in raising awareness on how to safely dispose of unused or expired medicines in Europe. Check the MedsDisposal website to discover more: http://medsdisposal.eu/get-involved/
Treatment to reduce brain inflammation shows ‘exciting’ results in mice.
Read more
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.